Reckitt Benckiser Group (LON:RKT) Earns “Overweight” Rating from Morgan Stanley

Reckitt Benckiser Group (LON:RKTGet Rating)‘s stock had its “overweight” rating reissued by Morgan Stanley in a research report issued on Sunday, Marketbeat reports. They presently have a GBX 7,000 ($91.07) price objective on the stock. Morgan Stanley’s price target points to a potential upside of 12.40% from the stock’s current price.

RKT has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 7,200 ($93.68) target price on shares of Reckitt Benckiser Group in a report on Tuesday, April 5th. JPMorgan Chase & Co. restated an “overweight” rating on shares of Reckitt Benckiser Group in a report on Monday, April 4th. Barclays raised their target price on shares of Reckitt Benckiser Group from GBX 8,800 ($114.49) to GBX 9,100 ($118.40) and gave the stock an “overweight” rating in a report on Friday, April 1st. Royal Bank of Canada restated a “sector perform” rating and set a GBX 5,500 ($71.56) target price on shares of Reckitt Benckiser Group in a report on Friday, April 1st. Finally, Berenberg Bank reduced their price target on shares of Reckitt Benckiser Group from GBX 7,480 ($97.32) to GBX 7,460 ($97.06) and set a “buy” rating for the company in a research report on Wednesday, March 23rd. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average target price of GBX 7,462.22 ($97.09).

Reckitt Benckiser Group stock opened at GBX 6,228 ($81.03) on Friday. The stock has a market capitalization of £44.52 billion and a PE ratio of -1,384.00. Reckitt Benckiser Group has a 12-month low of GBX 4,905.16 ($63.82) and a 12-month high of GBX 6,709 ($87.29). The company has a debt-to-equity ratio of 129.26, a current ratio of 0.62 and a quick ratio of 0.40. The firm has a 50 day simple moving average of GBX 5,934.85 and a 200-day simple moving average of GBX 6,026.86.

Reckitt Benckiser Group Company Profile (Get Rating)

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.